Impact BioMedical, Inc. (IBO) stock news · rev $32.0K
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
This IBO news page leads with what Impact BioMedical, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for IBO yet. We will not pad this page with generic market recap.
Latest reported IBO revenue for 2025-12-31 was $32.0K. Net income was -$11.8M. Revenue was down 36.0% from 2022-12-31 to 2025-12-31. IBO currently screens at market cap $7.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IBO stock page; for the tape open the quote page.
IBO stock news FAQ
What are IBO's latest revenue and net income?
Latest cached Impact BioMedical, Inc. (IBO) revenue for Dec 31, 2025 was $32.0K. Net income was -$11.8M. Statements: https://lician.com/financials/ibo
How did IBO revenue change from the prior cached period?
Cached Impact BioMedical, Inc. (IBO) revenue was down 36.0% from $50.0K (Dec 31, 2022) to $32.0K (Dec 31, 2025). Statements: https://lician.com/financials/ibo
What is IBO's market cap?
Impact BioMedical, Inc. (IBO) market cap is $7.6M on the latest cached fundamentals snapshot.
What kind of company is IBO?
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Where is IBO stock news listed?
Cached stock news for Impact BioMedical, Inc. (IBO) is listed at https://lician.com/news/ibo. Filings: https://lician.com/sec/ibo
Not investment advice.